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ABSTRACT
TITLE: A comparison of smokeless tobacco usage in two NCAA baseball programs
INTRODUCTION: Smokeless tobacco (ST) is commonly associated with baseball.
The purpose of this paper is to examine and compare the ST usage patterns on an
NCAA Division I baseball team and an NCAA Division III baseball team. The collected
data will be compared to patterns of use from similar age groups in a national survey. The
health effects of ST will be examined, along with the background of ST and baseball.
METHODS: An online survey was used to distribute and administer the questionnaire to
willing participants on the two college baseball teams. The survey was open from
October 29th, 2013 to February 1st, 2014, at which point the data was collected and
analyzed for patterns of use in SPSS. The results were then compared to smokeless
tobacco use rates in baseball players and student-athletes on the whole found by the
NCAA Student-Athlete Substance Abuse Surveys from 1997, 2001, and 2009.
RESULTS: The NCAA Division I baseball team had substantially higher rates of use,
both in terms of ever-use and habitual use when compared to the NCAA Division III
baseball team. On the Division I team, 75% of players reported ever-use and 62.5% of
players reported habitual use. On the Division III team, 35.7% of players reported everuse, while only 14.3% of players reported habitual use.
DISCUSSION: The survey found that the Division I team reported higher rates of use
than the Division III team, other NCAA student-athletes generally (75% ST ever-use and
62.5% habitual ST use compared to 17.4% of other student-athletes reporting past 12
month ST use) and higher use than other NCAA baseball players (75% ST ever-use and
62.5% habitual ST use compared to 52.3% of other NCAA baseball players reporting
past 12 month ST use),while the Division III team only reported only higher ever-use
than NCAA student-athletes on the whole reported use in the last 12 months, (35.7%
compared to 17.4%). The Division III team reported quite a bit less use than other
NCAA baseball players (35.7% ST ever-use and 14.3% habitual ST use compared to
52.3% past 12 month ST use in other NCAA baseball players). This is an awkward
comparison given the difference in definitions of use ever-use and habitual use versus
past 12 month use.
The major issue with the study was the lack of a large sample size, so the data
should be used cautiously. The rates on both teams would likely be closer had more
players responded to the survey. There was some difficulty in comparing this data with
the NCAA data given the different operational definitions smokeless tobacco use. The
NCAA asked about use in the last 12 months, while this survey asked about ever-use and
habitual use as determined by regularity and frequency of use.
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Chapter I
INTRODUCTION

1.1 Background
Smokeless tobacco use has long been associated with baseball in the United
States; particularly with Major League Baseball (MLB).

The practice has been

commonplace in the MLB since the 1880s when players used smokeless tobacco to keep
their mouths moist on the dry, dusty fields of the era (Connolly, Orleans, & Blum, 1992).
Though ever present, the use of ST increased in the 1970s and 1980s as the risks of
cigarette smoking became commonly known and ST companies began an aggressive
marketing campaign targeting professional baseball players (Severson, Klein,
Liechtenstein, Kaufman, & Orleans, 2005). This association has trickled down to amateur
levels of baseball, including National Collegiate Athletic Association (NCAA) baseball.
In the campaign against tobacco use, smokeless tobacco (ST) is often neglected or
forgotten. Smokeless tobacco (ST) is any form of tobacco that is consumed without
combustion. The two main types are moist snuff and chewing tobacco. Snuff is finely
cut or ground tobacco that is usually moist and typically packaged in a can or “tin.” It
comes in different types of cut (long cut, fine cut) and a variety of flavors. While usually
in loose form, snuff can also be found in the form of pouches with a pre-portioned
amount inside or in the form of dissolvable lozenges and strips. Chewing tobacco is
available as loose leaves, plugs (similar to a brick of tobacco that a users cut pieces off
for chewing), and twists of rope made of tobacco leaves. It is either chewed or held in
place on one side of the mouth, and the excess saliva produced is either spit or swallowed
(NCI Smokeless Tobacco Fact Sheet, 2010). It is far more visible than snuff and usually
Farrey 1

forms the distinctive cheek bulge that is thought of when one thinks of the smokeless
tobacco baseball players use.
A newer type of ST called snus has become available in the United States, though
it has long been available in Scandinavian countries. It is similar to snuff in that it can be
moist or dry and comes loose or in small pouches, but is pasteurized and is cured using
steam or a combination of steam and fire instead of fire alone, which considerably
reduces the levels of carcinogenic Tobacco-specific N-nitrosamines (TSNAs) present
(Lee, 2013). Other types of smokeless tobacco exist elsewhere in the world, such as the
Sudanese Toombak, Afghani Naswar, and Indian Gutka, and at least statistically, are far
more carcinogenic and harmful than the types of ST used in baseball. These types of ST
often include other additives (industrial lime, betel quid, etc.) that appear to create a
synergistic carcinogenic effect (Health, 1986). The types of ST presented here are the ST
products commercially available in the United States, with the focus being on moist snuff
and chewing tobacco, the two types of ST used almost exclusively in Major League
Baseball (MLB) (Boffetta, Hecht, Gray, Gupta, & Straif, 2008, Euromonitor
International, 2013).
Smokeless tobacco and baseball have a long and storied history. Many great
players were ST users such as Tony Gwynn and Babe Ruth, and many, like Chase Utley,
Nick Swisher, and Dan Uggla, still are. Major League Baseball now publicly discourages
its use and has put restrictions on its use in public in front of fans (autograph signings and
other public off-field appearances) but this has not stopped professional players from
continuing to use ST. Recent estimates of the prevalence of ST use in the MLB have
approached as high as 40-50%, though these rates do appear to be steadily declining over
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time (Cooper, Ellison, & Walsh, 2003). An outright ban on ST in the minor leagues has
not led to a substantial decrease in ST users in professional baseball either. Seeing
professional players use ST has long provided at least some influence on adolescent
baseball players to begin using; once beginning to use ST these new users can influence
their peers as well, thus perpetuating the cycle of smokeless tobacco and baseball
(Connolly, Orleans, & Blum, 1992, Eaves, 2011). MLB players should remember that
they are role models to a large number of children, who emulate behaviors of the people
they look up to. Hopefully, if enough professional players stop using ST or never start,
then the behavior will cease to trickle down and over time ST use and baseball will no
longer be associated with one another.

1.2 Purpose of Study
The purpose of this study is to measure and quantify patterns of ST use on an
NCAA Division I baseball team and an NCAA Division III baseball team, then compare
the data looking for differences between the two teams. After this comparison, this data
will be compared with survey responses from other NCAA student athletes.

1.3 Research Questions


How many players use ST on the NCAA Division I baseball team and how many
players use ST on the NCAA Division III baseball team? Does one team have more
ST users proportionately than the other? What percentage overall of each team uses
ST?



Are NCAA baseball players that play a particular position more likely to use ST?
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How do the collected survey results compare to other NCAA athlete survey
responses? Do the baseball players on these two teams use ST more or less than
other NCAA baseball players around the country?



How do the ST usage rates from the two surveyed teams compare to NCAA studentathlete data from years past?
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Chapter II
REVIEW OF THE LITERATURE
In this chapter, support for this study’s research questions is synthesized from the
scientific literature.

2.1 Pharmacodynamics of Smokeless Tobacco (ST)
ST is any kind of tobacco that is consumed orally without combustion. The most
common types available in the US and the two used in (and the types covered by this
document) include: moist snuff or “dipping tobacco” that comes in finely shredded form
or in pre-portioned pouches, chewing tobacco, which comes in loose leaf form, plugs (a
“brick” of tobacco), and braided ropes of tobacco As mentioned above, there are a wide
variety of other ST products around the world, but this document is limited in scope to
the two types sold in the continental United States most often used in MLB, moist snuff
and chewing tobacco (Boffetta, et al., 2008, Cooper, Ellison, & Walsh, 2003). ST, like
other forms of tobacco, is highly addictive due to the presence of nicotine.
Nicotine is specifically classified as a euphoriant that produces dose-dependent
changes in mood and feeling. Nicotine, like other addictive drugs, causes perceptible
neurological changes that are appealing to the user, thus reinforcing the nicotineadministering behavior, subsequently resulting in addiction. Over time, nicotine causes
neuroadaptation that leads to much higher tolerance and severe physiological
dependence, regardless of the route of nicotine administration. Users of ST appear to be
as addicted, if not more addicted, to nicotine than cigarette users. This is thought to be
due in part to the proximity of the buccal mucosa to the brain (Health, 1986).
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Once placed in the mouth, the nicotine from the smokeless tobacco is rapidly
absorbed into the bloodstream from the buccal mucosa, at levels as much as twice as high
as after smoking one cigarette (Fant, Henningfield, Nelson, & Pickworth, 1999). Fant et
al. (1999) assumed users of ST use approximately 2.5 grams per use, thus it is safe to
assume that many ST users use portions that differ in size from the doses studied in
Fant’s et al. controlled conditions.

This means it is possible that more nicotine is

delivered than in even two cigarettes. Based on the author’s observations during his
collegiate baseball career, many users of ST use two or more pouches of ST at once
instead of only one at a time.
Nicotine is most easily absorbed in its unionized form, which is PH dependent; as
PH rises, the unionized nicotine is more readily absorbed by the buccal mucosa. Thus,
not only the total nicotine content of a ST product is important, but the PH of the product
and the proportion of the total nicotine in unionized form are as well. The PH of ST
increases the longer it is exposed to saliva, thus increasing the amount of nicotine
absorbed by the user. After entering the bloodstream, the nicotine causes an increase in
heart rate, diastolic blood pressure, and systolic blood pressure. The increase in heart rate
ceases or begins to decline after approximately 15 minutes of nicotine absorption (Fant et
al., 1999).
Besides nicotine, ST contains a variety of harmful compounds, the most notable
being Tobacco-specific nitrosamines (TSNAs).

TSNAs form during the curing and

processing of the tobacco leaves, as well as from the formation of nitrate and nitrite by
bacteria

endemic to tobacco

(Rodu

& Jansson, 2004).

(methylnitrosamino)-1-(3-pyridyl)-1-butanone

(abbreviated

The
to

TSNAs

NNK)

4-

and N'-
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nitrosonornicotine (NNN) are believed to play a role in the development of a variety of
tobacco-related cancers, including cancers of the lung, esophagus, oral cavity, and
pancreas (Hecht, Carmela, Foiles, Murphy, & Peterson, 1993). Levels of TSNAs in ST
are unrelated to total nicotine, un-ionized nicotine, moisture, price, or market share
(Richter, Hodge, Stanfill, Zhang, & Watson, 2008).

Levels of TSNAs have fallen

considerably since the 1986 Surgeon General’s report, and continue to decrease due to
improved production, storing, and fermentation methods. It is interesting to note that
unlike levels of TSNAs which have decreased over time, nicotine content has remained
the same or increased since the Surgeon General’s report (Health, 1986, Brunnemann, Qi,
& Hoffmann, 2002). Whether the reductions in TSNAs will have an observable effect at
the population level remains to be seen.
Other harmful compounds include a variety of polycyclic aromatic hydrocarbons
(PAHs), which after TSNAs are the strongest carcinogens in ST, followed by trace
amounts of Polonium 210 (210Po) (Stepanov et al., 2010). PAHs are carcinogens formed
during the tobacco curing process, and traditionally from the incomplete combustion of
organic matter.

Chemicals classified as PAHs include Benzo[a]pyrene (BaP),

naphthalene, acenapthylene, anthracene, and fluorene (Stepanov et al., 2010). The
Polonium, along with other trace amounts of carcinogens like lead, formaldehyde,
cadmium, and Uranium 235 (235 U) are thought to be absorbed by the tobacco roots and
leaves from both the fertilizer and soil used during the growing of the tobacco before
being processed into ST (Brunnemann & Hoffmann, 1992).
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2.2 Health Effects of ST
In addition to the potent carcinogens present in ST, its use causes changes in oral
anatomical structures at the cellular level. A 1992 study by Daniels et al. found four
types of changes in 142 biopsy specimens from 133 professional baseball players that
were regular ST users.

The four types of changes were hyperparakeratosis,

hyperorthokeratosis, pale surface staining, and basal cell hyperplasia. Hyperparakeratosis
is the more technical term for leukoplakia, a white, premalignant plaque that often forms
in the mouths of ST users. Leukoplakia also often presents with hyperorthokeratosis, an
abnormal thickening of granular keratohyaline cells in the orthokeratin layer of the buccal
mucosa. Pale surface staining is a discoloration of the visible enamel on teeth; it usually
is yellowish or brownish in users of tobacco. Basal cell hyperplasia is an abnormal
thickening of basal cells in a given area of epithelium; this is typically in the area of the
mouth the user places the ST (Daniels et al., 1992).
While chemical and histological analyses are important, substantial research has
been done at the population level to determine the strength of the association between ST
and many varieties of cancer and cardiovascular disease. Older research (before 1990),
and research by a subset of specific authors (Boffetta and Winn, for example) have found
much higher correlations between ST use and cancer than newer studies have. In the
oldest studies, this is due, at least in part, to several factors: they often did not have
control groups, and if they did; there were no attempts to control for confounding
(Rosenfeld & Callaway, 1963, Landy & White, 1961, Wilkins & Vogler, 1957).
Once modern epidemiologic methods became standard practice, the accepted
format of case-control studies and retrospective cohort studies became common for
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studying the health risks of ST. In what has been considered the “landmark” study on
ST, Winn et al. (1981) found a remarkably increased RR for oral cancer in snuff dippers
in a case-control study done on North Carolina women. They found that the RR for
female snuff dippers that were nonsmokers was 4.2 (CI=2.6-6.7), and that among female,
long-term (>50 years), chronic users, the RR was increased by nearly 50 times. They
concluded that non snuff-dipping-related oral cancers resulted from the combination of
cigarette smoking and alcohol consumption (Winn et al., 1981). This nearly 50-fold
relative risk increase has since been generalized to all types of ST, all forms of oral
cancer, and this statistic became the status quo that has been repeated since.
Zhou et al. (2013) found a non-significant elevated risk for ever having used ST
and head and neck Squamous cell carcinoma (HNSCC) (OR 1.2, CI=0.67-2.16). They
also found a significant elevated risk for long term (>10 years) users of ST (OR 4.06,
CI=1.31-12.64). And most importantly, they found an elevated risk in ever-users of ST
compared to never cigarette smokers (OR 4.21, CI=1.01-17.57), suggesting that longterm ST use increases the risk for developing HNSCC and oral cancer (Zhou et al., 2013).
In another study, Alquacil and Silverman (2004) conducted a case-control study by
interview with residents of Atlanta, Detroit, and 10 counties in New Jersey. They found a
moderately increased risk of pancreatic cancer in subjects that used >2.5 ounces of ST a
week (OR 3.5, CI=1.1-11), and an increased risk in long-term ST users (OR 1.5, CI=0.64.0), though the latter statistic was non-significant (Alquacil & Silverman, 2004).
Large retrospective studies have also been done to attempt to quantify the risks of
ST use. Bjelke and Schuman (1982) published one of the earliest of the large cohort
studies; they found that in cohorts of 12,945 Norwegian men and 16,930 American men,
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there was an increased risk of dying from oral, pharyngeal, and esophageal cancers (RR
2.6-31, no CI reported), as well as an increased risk of developing pancreatic cancer (RR
2.9, no CI reported). Boffetta, Aagnes, Weiderpass, & Andersen (2005) retrospectively
examined a cohort of 10,136 Norwegian men that used snus and found the relative risk
(RR) of pancreatic cancer was 1.67 (CI=1.12-2.50), the RR of oral and pharyngeal cancer
was 1.10 (CI= 0.50-2.41), the RR of esophageal cancer was 1.40 (CI=0.61-3.24), and the
RR of stomach cancer was 1.11 (CI=0.83-1.48).

Luo et al. (2007) also found an

increased risk of pancreatic cancer in a retrospective cohort of 125,576 Swedish males
that were construction workers from 1978-1992. They calculated a RR of 2.0 (CI=1.23.3) compared with never users of tobacco (Luo et al., 2007).
Several case-control studies have found ST users have comparable or very
slightly increased risk of developing heart disease to never-users of ST, but the studies
have not been of large enough scale to confidently conclude that ST users experience no
increased risk over never-users (Huhtasaari, Lundberg, Eliasson, Janlert & Asplund
(1999). A handful of studies have found a moderately increased risk for cardiovascular
mortality, but there are fewer of these studies than studies finding no increased risk or
even a slightly decreased risk of cardiovascular mortality in ST users compared to neverusers (Bolinder, Alfredsson, Englund, & de Faire, 1994). Regardless of the impact ST
has on risk of cardiovascular mortality compared to never-users, researchers do agree that
ST confers a significantly smaller risk of a fatal cardiovascular event than does smoking
(Asplund, 2003).
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Despite the findings of the aforementioned studies, there are a small but
significant number of researchers that believe ST is definitely not as bad as smoking and
its health effects should be re-evaluated taking modern studies and improved ST
manufacturing methods into account (Rodu & Cole, 2002, Waterbor et al., 2004, Rodu
2011, Kozlowski 2007, Gartner & Hall, 2010). There are also those in the public health
field that are unwilling to openly admit any form of tobacco is less harmful, but are
willing to consider the possibility (Hatsukami, Lemmonds, & Tomar, 2004, Mejia, Ling,
& Glantz, 2010).
The prevailing school of thought is based on research collected and published by
the Surgeon General in a report on the health effects of ST in 1986 (Health, 1986), and
more specifically, on the aforementioned paper published in 1981 by Winn et al that
found a 50-fold increased risk of a particular type of oral cancer associated with dry snuff
in long-term (>50 years) female dry snuff users that used the product an average of 21
hours per day for 50 years or more (Winn et al., 1981).
A recent and extensive meta-analysis found little to no statistically significant
correlation between ST and cancer, though the meta-analysis was funded by the
European Smokeless Tobacco Council (Lee & Hamling, 2009). Lee & Hamling (2009)
performed a meta-analysis of 62 American and 18 Scandinavian studies and found
statistically significant increased risks only for oropharyngeal (OR 1.36 CI=1.04-1.77,
n=19) and prostate (OR 1.29 CI=1.07-1.55, n=4) cancers; though the association between
ST and oropharyngeal cancer disappeared in studies published since 1990 (OR 1.00
CI=0.83-1.20, n=14), and in studies that adjusted for alcohol (OR 1.07 CI=0.84-1.37,
n=10). Lee & Hamling (2009) also calculated that of 142,205 smoking-related male

Farrey 11

deaths in 2005, 1,102 (1.1%) would have been attributable to ST if as many men used ST
as smoked, and 2,081 (2.0%) if every man had used ST instead of smoking.
In the same year, Lee & Hamling (also 2009) published a commentary on the
differences in RR estimates reported by Boffetta et al. in their 2008 study and Lee &
Hamling’s own meta-analysis. The two analyses appeared to contain very similar bodies
of research, but Lee & Hamling found significantly lower RR estimates than Boffetta and
his colleagues did for ST use overall and several different cancer sites. Lee & Hamling
(2009) used pre-defined criteria and included all studies that met the inclusion criteria
(Boffetta et al. did not), as well as reporting separate RR estimates with studies that
adjusted for smoking and those that did not (Boffetta et al did not). Using the same
studies as Boffetta et al. (2008), Lee & Hamling (2009) found estimated RR increases of
<15% for esophageal, pancreatic, and lung cancers (Boffetta et al. found a non-significant
increased risk of <20% for lung cancer and found statistically significant increased risks
of 60-80% for esophageal, pancreatic, and oral cancers), and an increase of 36% for oral
cancer.
These findings suggest there has been some publication bias in the field of ST
research. When all applicable studies are considered, the purported increased risk of
developing cancer due to ST use possibly approaches that of never-users of ST, though
this is controversial at best. The oft-reported 50-fold increased risk taken of oral cancer
from Winn et al. (1981) also approaches that of non-users when only studies performed
since 1990 are considered; this also is indicative of either shoddy epidemiology or some
sort of bias, but influence from the tobacco industry cannot be entirely ruled out in some
recent studies. Though older studies found significantly increased risk for developing
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cancer with ST use, newer studies and meta-analyses have found minimal or no increased
risk of oral cancer, other forms of head and neck cancer, or pancreatic cancer (Rodu &
Cole, 2002, Bouquot & Meckstroth, 1998, Weitkunat, Sanders, & Lee, 2007). More
research is needed to more conclusively determine the risks of ST use; though in the
meantime, professional and amateur baseball players alike will likely continue to use ST
regardless of the potential health risks.

2.3 ST Use in Baseball
Smokeless tobacco (ST) and professional baseball, Major League Baseball
(MLB), have been almost synonymous for over a century.

ST was first used in

professional baseball to keep the player’s mouths moist during games as fields were
significantly dustier than present fields (Eaves, 2011).

Even after fields became

professionally groomed, the practice of using ST during baseball games continued.
Baseball offers the ideal environment for an ST user as the risk of physical injury or
physical contact while playing baseball is comparatively low when other sports are
considered. Combined with the stopping and starting nature of baseball, this creates an
environment where ST is accepted and even encouraged by peer reinforcement,
superstition, and other ritualistic behavior unique to baseball.

In college athletes

especially, this can translate to increased ST usage off the field (Eaves, 2011).
At the end of the 19th century and the beginning of the 20th, using ST was not as
uncommon or socially unacceptable as using ST now. ST usage in the US used to be
significantly higher; until 1918 it was the predominant form of tobacco use in the US
(Boffetta et al., 2008). After a decline in use due to the rise in cigarette smoking because
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of the development of automated cigarette production, ST rose in popularity again during
the 1960s and 1970s after the dangers of cigarette smoking became more apparent and
publicly known (Boffetta et al., 2008). It was during this period that ST companies began
providing free ST to professional baseball teams and initiated an aggressive marketing
campaign targeting professional baseball players (Eaves, 2011).
The first epidemiological studies investigating the prevalence of ST usage in
MLB and other levels of play began to appear during the next several decades. Studies
have shown that the prevalence of ST use appears to rise with age, or the longer a player
has played baseball (from high school to college, from college to professional). Davis et
al. (1997) took a survey of 1200 male high school athletes and found that 21% chew
tobacco and 18% used moist snuff. Walsh, Ellison, Hilton, Chesney, & Ernster (2000)
found that 15% of the surveyed California public school baseball players were current ST
users, and 46% were considered “ever-users.” These numbers are significantly higher
than ST usage in high school age groups on the whole; Agaku, Vardavas, Ayo-Yusuf,
Alpert, & Connolly (2013) reported that 7.1% (CI=5.5-8.6%) of 15-17 year-olds and
10.1% (CI=7.4-12.8%) of all 18 year-olds surveyed reported using ST in 2011. It is also
possible that the numbers presented in studies of high school students are conservative;
the data are potentially impacted by high school players more unwilling to admit to
purchasing and using tobacco than college or professional populations because ST is
illegal to purchase until age 18 and its use is unequivocally illegal in all high school
sporting events.
Studies of collegiate baseball players have found comparable or higher rates of ST
use on baseball teams than in high school.

Gingiss & Gottlieb (1991) found
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approximately 53% of varsity baseball players and 25.9% of intramural baseball players
surveyed used either chewing tobacco or moist snuff.

Walsh, Hilton, Ernster,

Masouredis, & Grady (1994) found that 52% of varsity collegiate baseball players
surveyed in their study (N=1,328) were current users of ST, and 41% of these users
initiated use in high school. The NCAA National Study of Substance Use Trends Among
NCAA Student-Athletes (2012) found that 41.5% of surveyed varsity collegiate baseball
players used ST in 2005, and in 2009, 52.3% used ST (Bracken, 2013). Additional recent
studies are sparse and do not seem to be available, leaving a considerable gap in the ST
literature for the last ten years.
This scarcity has not been present for studies about ST use in professional
baseball. Studies about the prevalence of ST use and the health effects it has had on the
players started being published in the mid 1980s. A study administered during spring
training in 1987 surveyed 265 players from seven different MLB teams and found that
34% of players were current ST users (Connolly, Orleans, & Kogan, 1988). Wisniewski
and Bartolucci (1989) surveyed 528 MLB players on 25 of the 26 MLB teams during
spring training the same year (1987) and reported that 46% were current ST users. Other
peer-reviewed literature from 1988-1997 found rates of ST usage of 44%, 40%, 35%,
41%, and 35% respectively, in samples of MLB players (Ernster et al., 1990, Green et al.,
1992, Green, Walsh, & Masouredis, 1994).
More recent studies have found encouraging results compared to the studies in the
late 80s and 90s. Sinusas and Coroso (2006) found a marked decrease in the overall
prevalence of ST use in a sample of Major League Baseball players over a ten year period
(1991-2000), from 41.1% in the first year to 25.6% in the tenth year. Another six year -
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long study from 1998-2003 found MLB players’ self-reported ST use drop from 31.7% in
1998 to 24.8% in 2003 (Severson et al., 2005). Over time it seems the campaigns to
reduce tobacco use in the professional baseball ranks have been somewhat successful,
though ST usage rates in the MLB are still far too high.
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Chapter III
METHODS AND PROCEDURES

3.1 Context and Rationale of Study
There are a multitude of studies about ST use in baseball at the professional level,
but there are relatively few studies about ST use in baseball at the collegiate level. ST in
general, needs far more research before an educated view about its health effects can be
made, and baseball teams provide a population that is likely to contain a sizable
percentage of ST users. The purpose of this study is to add to the small body of research
about the prevalence of ST use in collegiate baseball.

3.2 Study Instrumentation and Study Population
After obtaining Institutional Review Board approval from Georgia State
University (GSU) and Oglethorpe University (OU), the attached survey (see Appendix A)
about ST use was administered online to volunteer participants from GSU’s varsity
baseball team and OU’s varsity baseball team, along with a waiver of documentation of
consent (see Appendix B). The survey was written by the author, with input from his
thesis advisor and is based on his personal experience in collegiate baseball. It is
designed to investigate patterns, origins, and cultural norms of ST use in collegiate
baseball.

It consists of 26 items, and was administered on Qualtrics’ website

(Qualtrics.com) and a unique link to the team’s respective survey was sent to each player.
Participation was voluntary and anonymous, and the data obtained from both GSU
players and OU players was hosted on secure, off-campus servers, and were tallied and
examined separately, before being combined into a single data set for analysis.
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Both surveys were activated on October 29, 2013. Players from both teams were
given approximately three months to complete the survey during which time a schoolspecific email invitation (see Appendix C) and two reminders to complete the survey
were sent. On February 1st, the survey was closed and the data was compiled and
analyzed.

3.3 Study Measures
As this is a prevalence study, the main variables of interest are the demographic
variables and whether or not survey respondents have ever used ST, and whether they
consider themselves to be habitual users of ST. The variables chosen indicate a rough
estimate of the prevalence of ST use on each team along with common demographic
characteristics.
Age was defined as the present age of the survey participant at the time of the
survey based on the participant’s answer to “How old are you?” Race/Ethnicity was
defined as the race indicated by survey participants on the question, “What ethnic group
do you consider yourself to be a part of?” Current year of NCAA athletic eligibility was
defined as the survey participant’s indicated year of collegiate athletic eligibility on the
question, “What is your current year of college eligibility?”

Under normal

circumstances, student-athletes are given four years of athletic eligibility in which they
can compete. There can be a fifth or even sixth year granted due to injury or personal
hardship. This question was asked to determine if status or length of time within the
baseball program impacted the likelihood of a player to use ST without factoring in age.
The last demographic variable, Position player or pitcher, was determined by the survey
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participant’s answer to the question, “Are you a position player or pitcher (if both, which
do you consider to be your primary role)?” Pitchers tend to have more downtime when
compared to position players given the nature of their role in the game of baseball. This
question was asked to determine whether or not this added downtime had any impact on
ST use. The last variable that was focused on was Opinion of ST, which was defined as
the survey participants’ answer to the question, “Does ST use bother or offend you in any
way?” The variable question labels were altered so as to make statistical analysis more
practical, and charts more readable, as shown below (Table 3.1).
Table 3.1 Modified labels
“How old are you?” = Age
“What ethnic group do you consider yourself a part of?” = Race/Ethnicity
“What is your current year of college eligibility?” = Current year of eligibility
“Are you a position player or pitcher (if both, which do you consider to be your
primary role)? = Position player or pitcher
“Does ST use bother or offend you in any way?” = Opinion of ST

“Have you ever used ST?” or ever-use of ST, was defined as having ever (even
once) used ST under any circumstances and was indicated by the player’s answer to that
survey question. “Do you consider yourself to be a habitual ST user?” or Habitual ST
use, was defined by the author as daily ST use or ST use on most days. Habitual ST use
was determined based on the player’s answer to that particular survey question.
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3.4 Statistical Analysis
The data from Qualtric’s secure servers was downloaded and exported to SPSS
(Statistical Package for the Social Sciences), where the statistical analysis was performed.
Cross tabulations, frequency tables, and descriptive statistics were run to look for patterns
of ST use on each team and any associations present between demographic variables and
whether or not a respondent used ST. During the analysis, Chi square tests with p values
of 0.05 were utilized to determine statistical significance between groups, if applicable.
Though assessing ST prevalence was the primary aim of the study, players were also
assessed based on their opinions and attitudes about or towards ST use. Player responses
to the question “Does ST use bother or offend you in any way?” were compared by
school, and Age, Race/Ethnicity, Current Year of College Eligibility, and Position Player
or Pitcher as defined above were each run against “Have you ever used ST?” and “Do
you consider yourself to be a habitual ST user?” These demographic measures compared
to ST use, along with the prevalence of ST use were the primary interests of
administering the survey.

The following section presents the aforementioned cross

tabulations along with the pertinent Chi square values where applicable, though the full
results from the survey can be found in Appendix E.
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Chapter IV
RESULTS
The following section will describe the findings of this cross-sectional prevalence
study and address the following research questions:

4.1 Study Population
In total, 31 varsity baseball players were contacted by email about the survey at
GSU and 35 varsity baseball players were contacted about the survey at OU. Player
information was obtained from the student directory for each school respectively. There
were 9 responses from GSU, giving a 29% response rate, and 15 from OU, giving a
42.85% response rate, though one survey from each school was incomplete and thus
omitted from the analysis.

4.2 Age and ever-use of ST
The age distribution was nearly uniform in OU survey respondents (Table 4.1).
Of these respondents, 20-year-olds were the most likely to report ever-use of ST (66.7%),
followed by participants that were 22 and older (50%).

There was no statistically

significant association between any age and ever-use of ST in respondents from OU
(Table 4.2) (χ=3.471, p=.482). The age distribution of GSU survey respondents was less
uniform (Table 4.1). Like OU players, GSU 20-year-olds had the highest prevalence of
ever-use of ST, with 100% of them reporting ever-use. There was no age associated with
an increased likelihood of being an ever-user of ST in GSU players either (Table 4.2)
(χ=2.597, p=.627). Overall, 11 survey respondents in total reported ever-use of ST,
meaning 50% of the study population reported ever-use of ST.
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4.3 Race/Ethnicity and ever-use of ST
All respondents from both schools identified themselves as White (14 from OU,
eight from GSU, shown in Table 4.1). 35.7% of respondents from OU identified as everusers of ST and 75% of respondents from GSU identified as ever-users of ST. There was
not a valid Chi-Square value as Race/Ethnicity was a constant. Overall, all 11 survey
participants that reported ever-use of ST were White.

4.4 Current year of eligibility and ever-use of ST
Three freshmen, four sophomores, two juniors, three seniors, and two other
responded to the survey invitation from OU for a nearly even distribution. Players with
fewer years of eligibility remaining were more likely to report ever-use of ST, with the
exception of the “other” group (50% of sophomores, 50% of juniors, and 66.7% of
seniors) (Table 4.1). None of these values were statistically significant (Table 4.2)
(χ=5.662, p=.229).
The distribution of year of eligibility was similar in survey respondents from
GSU. Like OU, the distribution of current years of eligibility in GSU respondents was
very nearly uniform. Of the GSU players that responded, 50% of freshmen, 100% of
sophomores, 100% of juniors, 0% of seniors, and 100% of others identified themselves as
ever-users of ST at GSU (Table 4.1). Like OU, there was not a statistically significant
association present in GSU players (Table 4.2) (χ=2.597, p=.667). Seven of the 11 total
players that indicated ever-use of ST were juniors or above (Table 4.1).
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4.5 Position player or pitcher and ever-use of ST
Ten survey respondents identified themselves as position players and four survey
respondents identified themselves as pitchers from OU (Table 4.1). Pitchers from OU
were more likely to report ever-use of ST, with 30% of position players and 50% of
pitchers identifying themselves as ever-users of ST. Neither of these values was
statistically significant (Table 4.2) (χ=.052, p=.819). By comparison, five survey
respondents from GSU identified themselves as position players and three survey
respondents from GSU identified themselves as pitchers (Table 4.1). Thus position
players from GSU were more likely to report ever-use of ST; though pitchers were still
very likely to report ever-use of ST as well (80% of position players and 66.7% of
pitchers identified themselves as ever-users of ST). There was not a statistically
significant correlation in GSU players (Table 4.2) (χ=.637, p=.425). Of the 11 total
players that indicated ever-use of ST, more position players reported ever-use of ST than
pitchers (seven versus four) (Table 4.1).

Table 4.1 – Ever-use of ST by School
GSU (n=8)
Percent of
School

N

Total (N=22)

OU (n=14)
Percent of
School

N

Percent of
Total

N

Age
18

1

12.5%

0

0%

1

4.5%

19

0

0%

1

7.1%

1

4.5%

20

3

37.5%

2

14.3%

5

22.7%

21

0

0%

1

7.1%

1

4.5%

22 or older

2

25%

1

7.1%

3

13.6%

Race
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White

6

75%

5

35.7%

11

50%

Freshman

1

12.5%

0

0%

1

4.5%

Sophomore

1

12.5%

2

14.3%

3

13.6%

Junior

2

25%

1

7.1%

3

13.6%

Senior

0

0%

2

14.3%

2

9.1%

Other (Redshirted)

2

25%

0

0%

2

9.1%

Position Player

4

50%

3

21.4%

7

31.7%

Pitcher

2

25%

2

14.3%

4

18.2%

Year of Athletic
Eligibility

Position

Table 4.2 – Chi-Square Tests for Ever-use of ST
All variables stratified

Have you ever used ST?

Value

df

Asymp. Sig.

by school

(2-sided)
Yes

Pearson Chi-Square

3.471

4

.482

No

Pearson Chi-Square

2.597

4

.627

Current Year of

Yes

Pearson Chi-Square

5.622

4

.229

Eligibility

No

Pearson Chi-Square

2.597

4

.627

Yes

Pearson Chi-Square

.052

1

.819

No

Pearson Chi-Square

.637

1

.425

Age

Position

4.6 Age and habitual ST use
The differences in habitual use between the two teams were striking but not
statistically significant. OU players reported less habitual ST use than GSU players.
There was one 20-year-old OU player and one OU player that was 22 or older that selfidentified as habitual ST users, giving OU players an overall rate of 14.3% (two out of
14) for habitual ST use (Table 4.3). Somewhat surprisingly, these values were not
statistically significant (Table 4.4) (χ=.875, p=.646).
GSU players reported more habitual ST use than OU players. Overall, 62.5% of
GSU players that completed the survey reported habitual ST use, dwarfing the 14.3% of
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OU players reporting habitual ST use (Table 4.3). Also surprising was the lack of a
statistically significant association with GSU players (Table 4.4) (χ=6.0, p=.199).
20-year-olds reported more habitual use than any other age group. Seven players
total reported habitual use, while six players reported use, but not habitual use, leaving no
observable patterns (Table 4.3).

4.7 Race/Ethnicity and habitual ST use
Table 4.6 shows habitual ST use stratified by Race/Ethnicity on the two teams.
All respondents from both teams that completed the survey self-identified as White. As
mentioned above, a far greater percentage of GSU players indicated habitual use; only
14.3% of OU players compared to 62.5% of GSU players that completed the survey
identified themselves as habitual ST users (Table 4.3). Race/Ethnicity was a constant so
Chi square values were not calculated.

4.8 Current year of eligibility and habitual ST use
There were only two OU players that reported habitual ST use out of the 14 players that
completed the survey; a sophomore and a senior (Table 4.3). This gave OU players a
non-significant overall prevalence of habitual ST use of 14.3% (Table 4.4) χ=4.55,
p=.337). Of GSU players, one freshman, one sophomore, two juniors, and one player
that had redshirted indicated habitual ST use (Table 4.3). This gave GSU players an
overall prevalence of 62.5%, much higher than the 14.3% reported by OU players. There
was not a statistically significant association present in GSU players either (Table 4.4)
(χ=6.0, p=.199). Overall, seven players indicated habitual ST use, and six indicated ever-
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use of ST. There were not any perceivable patterns in Current year of eligibility when
the teams were compared side by side, though sophomores and juniors were more likely
to have reported habitual use than other classes.

4.9 Position player or pitcher and habitual ST use
One OU position player out of ten that responded (10%) and one pitcher out of
four that responded (25%) identified themselves as habitual ST users, meaning OU
pitchers were more likely to report habitual ST use than position players, albeit not by a
large or statistically significant margin (Table 4.4) (χ=.058, p=.809). Three out of five of
GSU position players (60%) that responded and two out of three GSU pitchers (66.7%)
identified themselves as habitual ST users, meaning GSU pitchers were slightly more
likely to report habitual ST use than position players (Table 4.3). There was not a
statistically significant association present in GSU players either (Table 4.4) (χ=.600,
p=.439). Between both teams, one more position player than pitcher reported habitual ST
use, though there did not appear to be any perceptible patterns (Table 4.3).
Table 4.3 – Habitual ST use by School
GSU (n=8)
Percent
of School

N

Total (N=22)

OU (n=14)
Percent
of School

N

Percent
of Total

N

Age
18

1

12.5%

0

0%

1

4.5%

19

0

0%

0

0%

0

0%

20

3

37.5%

1

7.1%

4

18.2%

21

0

0%

0

0%

0

0%

22 or older
Race

1

12.5%

1

7.1%

2

9.1%

White
Year of Athletic

5

62.5%

2

14.3%

7

31.8%
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Eligibility
Freshman

1

12.5%

0

0%

1

4.5%

Sophomore

1

12.5%

1

7.1%

2

9.1%

Junior

2

25%

0

0%

2

9.1%

Senior

0

0%

1

7.1%

1

4.5%

Other (Redshirted)

1

12.5%

0

0%

1

4.5%

Position Player

3

37.5%

1

7.1%

4

18.2%

Pitcher

2

25%

1

7.1%

3

13.6%

Position

Table 4.4 – Chi-Square Tests for Habitual ST Use
All variables stratified

Have you ever used ST?

Value

df

Asymp. Sig.

by school

(2-sided)
Yes

Pearson Chi-Square

.875

2

.646

No

Pearson Chi-Square

6.000

4

.199

Current Year of

Yes

Pearson Chi-Square

4.550

4

.337

Eligibility

No

Pearson Chi-Square

6.000

4

.199

Yes

Pearson Chi-Square

.058

1

.809

No

Pearson Chi-Square

.600

1

.439

Age

Position

4.10 School and opinion about ST
GSU players were less likely to be bothered or offended by ST use than OU
players. 87.5% of GSU players surveyed were not bothered or offended by ST use, while
only 57.1% of OU players surveyed were not bothered or offended by ST use (Table 4.9).
Overall, 68.2% of players surveyed from both schools were not bothered or offended by
ST use, but there was not a statistically significant association present (χ=2.986, p=.225).

Farrey 27

Table 4.9 School stratified by opinion about ST
Does ST use bother or offend you in any way? * School Crosstabulation
School
GSU
Count

Yes
Does ST use bother or
offend you in any way?

4

4

0.0%

28.6%

18.2%

1

2

3

12.5%

14.3%

13.6%

7

8

15

87.5%

57.1%

68.2%

8

14

22

100.0%

100.0%

100.0%

Count
% within School
Count

No

% within School
Count

Total

% within School

OU
0

% within School

Not Sure

Total

Chi-Square Tests
Value

df

Asymp. Sig. (2sided)

Pearson Chi-Square

2.986

2

.225
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Chapter V
DISCUSSION AND CONCLUSION
5.1 Discussion of Research Questions

How many players use ST on the NCAA Division I baseball team and how many
players use ST on the NCAA Division III baseball team? Does one team have more
ST users proportionately than the other? What percentage overall of each team
uses ST?
The survey results showed that six out of eight players that responded from GSU
have ever used ST, giving a prevalence rate of 75%, while only five out of 14 players that
responded from OU used ST, giving a prevalence rate of 35.7%. More players said they
had ever used ST on the NCAA Division I baseball team both proportionately and in
absolute terms than the NCAA Division III baseball team (6/8 versus 5/14). The results
were more polarized when habitual ST use was concerned; five out of eight (62.5%)
players that responded from GSU identified themselves as habitual ST users, while only
two out of 14 (14.3%) players that responded from OU identified themselves as habitual
ST users. Self-identified habitual ST use was far more likely and prevalent on the NCAA
Division I baseball team than on the NCAA Division III baseball team, though the Chi
square values did not indicate any statistically significant associations on either team.
The variables Age, Race/Ethnicity, Current year of collegiate eligibility, and
Position player or pitcher were not statistically significantly associated with ever-use of
ST or habitual use of ST. While ST use can certainly begin during collegiate baseball,
many players start before they come to college and continue during their collegiate
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careers as well, which is why age was not expected to show a statistically significant
association with either ever-use of ST or habitual use of ST. Given the survey
demographics, every player that responded from both teams identified themselves as
White. This is not surprising given the numbers of that particular racial group on both
teams, but it was surprising that no Black players or Hispanic/Latino players responded at
all.
Year of collegiate eligibility was not associated with ever-use of ST or habitual
use; this was interesting in that the older one gets, the more likely one is to use ST in
competitive baseball. It was expected that the higher rates of ST ever-use or ST habitual
use on each team would have been present in juniors, seniors, or redshirt juniors/seniors.
This was surprising because the Division III team was expected to have a higher
percentage proportionately of ST users than the Division I team based on the author’s
personal experience having played both NCAA Division I baseball and NCAA Division
III baseball. The data is likely misleading though, as the prevalence rate of ST use on the
GSU, the NCAA Division I team is unlikely to be as high as 75%. Had more players
responded to the survey, the prevalence of ST use found on each team likely would have
been much closer, while still being much higher than the prevalence rate of ST use in the
general population.

Are NCAA baseball players that play a particular position more likely to use ST?
Position players from OU were somewhat less likely to have ever used ST (three
out of 10; 30%) than pitchers (two out of four; 50%). GSU position players on the other
hand were somewhat more likely to have ever used ST (four out of five, 80%) than
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pitchers (two out of three, 66.7%). OU position players were less likely (one out of ten;
10%) to self-identify as habitual ST users than pitchers (one out of four; 25%). GSU
position players (three out of five; 60%) and pitchers (two out of three; 66.7%) were
comparably likely to self-identify as habitual ST users. None of the Chi square values
were statistically significant, but based on the player responses, position players appear to
be somewhat more likely to have ever used ST and habitually use ST than pitchers. This
perception is certainly influenced by the small number of players that responded to the
survey and the small sample size generally.
These results were interesting because position players have substantially less
downtime than pitchers, so it was thought that pitchers might be more likely to have used
or habitually use ST. Unless a pitcher is physically on the pitching mound, pitching in
the game, he is more than likely sitting down watching on the bench or in the bullpen for
hours at a time, with generally very little to do. This would lead one to believe that
pitchers might be more inclined to use ST, but according to the data collected from the
OU and GSU players, that would not seem to be the case.

How do the collected survey results compare to other NCAA athlete survey
responses? Do the baseball players on these two teams use ST more or less than
other NCAA baseball players around the country?
The most recent available data collected by the NCAA is from 2009 and it
reported that 27.2% of male student-athletes reported some form of ST use in the last 12
months. If both genders of student-athletes are considered, 17.4% report ST use in the
past 12 months. When only baseball players are considered, 52.3% of NCAA student-
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athletes reported ST use in the past 12 months (Bracken 2013). Based on this data, OU
baseball players were less likely than other NCAA varsity baseball players to have used
ST. GSU baseball players were equally likely or even more likely to have used ST than
other NCAA varsity baseball players.
It should be noted that the NCAA asked about past 12 month use of ST, while this
survey asked about ever-use, past 30 day use, and habitual use of ST. So when comparing
the rates of ST use found in this survey, the rates of habitual ST use reported by GSU and
OU were used for comparison with the past 12 month ST usage rates found in 2009 by
the NCAA (see Study Strengths and Limitations below).

How do the ST usage rates from the two surveyed teams compare to NCAA studentathlete data from years past?
Previous NCAA student-athlete substance abuse studies (1997, 2001) have found
lower rates than their most current study has (2009). Overall ST use in all NCAA
student-athletes was 22.5% in 1997, and fell to 17.4% in 2001. The NCAA Substance
Abuse studies in 1997 and 2001 found that 45.6% and 41% of varsity collegiate baseball
players reported ST use in the past 12 months respectively (NCAA, 1997, NCAA, 2001).
Compared to the past two NCAA student-athlete substance abuse studies, overall studentathlete ST use remained unchanged at 17.4%, but baseball-specific ST use rose to 52.3%
in the 2009 study (Bracken, 2013).
GSU baseball players were more likely to use ST habitually than NCAA studentathletes generally and baseball players specifically, on average than in the past studies in
1997 in 2001. OU baseball players were quite a bit less likely to use ST habitually than
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NCAA student-athletes generally and baseball players specifically, on average than in the
past studies in 1997 in 2001 as well. As mentioned above, these NCAA surveys asked
about past 12 month use, while this survey asked about ever-use, past 30 day use, and
habitual use. Subsequently, the rates of habitual ST use in GSU and OU players
measured by this survey were used to compare with the past 12 month rates of ST use
found in the previous two NCAA student-athlete substance abuse studies (See Study
Strengths and Limitations below).

5.2 Study Strengths and Limitations
A very significant limitation of this study was that the sample size of this study
was too small for the results to be statistically stable or significant. There is a
considerable possibility that some of the results were distorted given the small number of
survey respondents. The observed patterns in the data were likely not indicative of the
overall prevalence rates of the two teams; GSU’s baseball team is unlikely to have as
high a prevalence of ST use as was found in the survey, and OU’s baseball team is likely
to have somewhat higher prevalence of ST use than was found in the survey. As
measured by the survey, GSU’s baseball team was well above the national average for
varsity collegiate baseball programs and OU’s baseball team was well below the national
average for varsity collegiate baseball programs. One survey response from each school
was incomplete and omitted from the final analysis. If these two responses had been
completed they likely would have influenced the final results to an extent as well.
Another limitation from the analysis is that the results are not generalizable to the
general population. This may be a strength of the study when considering collegiate
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athletes or collegiate baseball players specifically, but those populations are not
representative of the public. This data may help contribute to the relatively small pool of
data on ST use in collegiate baseball players, and may be more accurate to an extent in
the sense that players may feel more comfortable being honest about their ST habits to
someone not affiliated specifically with the governing body of the sport they participate
in, the NCAA.
As mentioned above, an oversight regarding survey question design occurred; the
NCAA Student-Athlete Substance Abuse studies asked all student-athletes whether they
had used ST in the past 12 months, while the survey administered to GSU and OU
players did not ask about past 12 month use. Given the difference in the survey questions
asked by this survey and by the NCAA, it was thought that the rates of Habitual ST use
found by this study would most likely include the past 12 month interval chosen by the
NCAA. During the writing of this survey, past 12 month use was not an amount of time
thought of as a relevant interval, as one-time users could very well be pooled with regular
users, the demographic of concern when trying to measure the overall prevalence of this
type of behavior. Counting a player that tried ST one time in the fall while off season but
did not continue to use it should not be considered the same as a player that used ST
multiple times daily, like in the NCAA surveys. This survey asked about the two
scenarios separately, meaning the results from each question were more specific. Asking
about past use in the last 12 months is useful for other substances; anabolic steroids, for
example. It was only after the fact that the difficulty in accurately comparing habitual
use or past 30-day use to use in the last 12 months became apparent. If the survey
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utilized in this study was used again, past 12 month use of ST would be added as a
question.
Another limitation is the lack of incentive to participate in the survey; more
players would likely have responded to the survey invitations had there been a monetary
reward or some other sort of reward attached to survey participation. More players also
might have responded if baseball was “in-season,” though this is unclear as baseball
players practice year-round. There is baseball in the fall, followed by “unofficial
practices” in the winter, then the season beginning in the spring.
Lastly, there was a discrepancy in the survey data regarding ever-use and habitual
use in OU players. Two OU players changed their answer from never-use to some use,
but not habitual use when asked about habitual use. The different answers did not change
the statistical significance, but should be noted nevertheless.

5.3 Recommendations for Future Research
In general, there should be more research on the long-term health effects of ST,
but this research should strictly control for other risk factors of disease, include every
study that meets the predefined inclusion criteria, and not attempt to fit data to support a
preexisting belief about ST. Researchers should at least consider the population effects
of a large number of smokers switching to ST and the potential for different outcomes at
the population level. If a researcher was to follow collegiate baseball players that
habitually used ST over the long-term, it might give the scientific community a study
representative of the least serious health outcomes in a population since athletes tend to
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be in far better physical shape than the rest of the population, and are potentially less
likely to also use cigarettes concurrently.
This study would have worked better on a far larger scale with many more teams,
preferably in different geographic locations or even multiple teams in the same
conference but different locations. Far more survey participants are needed for the data
to have the stability needed to be taken as representative of the collegiate baseball
student-athlete population. Repeating this survey with a good sample size would likely
produce interesting results. A viable sample size might be all of the Division I and
Division III teams in Georgia, or all of the Division I teams in the NCAA Southeastern
Conference compared to all of the Division I teams in the NCAA Pacific-12 Conference,
along with two comparable conferences in Division III baseball, though an even larger
sample size would be even better.

5.4 Conclusion
ST and baseball have been associated with each other for over a century. This
proclivity to use ST filters down by age, beginning (at least in terms of what has been
researched) in high school, continuing and increasing in college, and finally at the
professional level in MLB, where all of these players likely learned about ST use in the
first place. There has been a strong and vocal campaign against ST use in MLB and its
affiliate minor leagues by a multitude of different parties, varying in strength from
grassroots organizations all the way up to a discussion in congress. The campaigns
appear to have been somewhat successful, as rates of ST use in the MLB ranks have
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fallen from 40-45% to 25.6% in the last two decades (Wisniewski & Bartolucci, 1989,
Sinusas & Coroso, 2006).
The trend does not appear in younger players; rates of ST use in amateur baseball
players appear to rise with age. Studies have shown high school baseball player ST use
varied between 15-21% (Davis et al., 1997, Walsh et al., 2000). Multiple studies have
found rates of ST use in varsity collegiate baseball players that vary from between 5052% (Bracken, 2013, Gingiss & Gottlieb, 1991, Walsh et al., 1994). The data collected
from GSU and OU presented here fall on either side of the approximately 50% estimates;
ever-use and habitual use is far higher on GSU, the NCAA Division I baseball team (75%
& 62.5%, respectively), than on OU, the NCAA Division III baseball team (35.7% &
14.3%, respectively). These numbers are most certainly affected by the small sample size
(GSU, N=8, OU, N=14) and that reduces their statistical power considerably, as it is not
possible to definitively determine the prevalence of ST use on either team based on such
a small sample. Regardless of the true prevalence of ST use in the study population and
in collegiate baseball on the whole, the best chance public health professionals have to
potentially reduce the number of ST users in collegiate baseball is by continuing to
discourage ST use in the MLB. Then hopefully as more professional players quit or
never begin using ST in the first place, the effect will seep down the skill levels so that it
is no longer a major part of baseball culture.
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Appendix A – OU IRB Approval

Date: August 21, 2013
To:
Andrew Farrey, Principal Investigator
Oglethorpe University
From: Brad Stone, Ph.D., Chair
Oglethorpe University Institutional Review Board for Research with Human Participants
Re:
A comparison of smokeless tobacco usage (ST) in two NCAA baseball programs and the National
College Health Assessment smokeless tobacco data
Dear Mr. Farrey:
I am writing in regards to your study, “A comparison of smokeless tobacco usage (ST) in two
NCAA baseball programs and the National College Health Assessment smokeless tobacco data,” for which
you requested an expedited review. My review of your proposal convinced me that your study involves no
more than minimal risk to participants, no unreasonable deception, and no additional ethical concerns that
would warrant a full board meeting. Consequently, I approved the expedited review and proceeded to
examine the proposed methodology, evaluating it vis-à-vis the ethical standards presented in the DHHS
Federal Code of Regulations Title 45, Part 46, the Belmont Report, and the Office for Human Research
Protections.
Based upon my review I concluded that your study poses minimal risk for participants, that your
protocol is straightforward and involves no unreasonable deception, and that you have taken adequate steps
to guarantee the confidentiality of all potential participants.
Based on the information you have provided, I am confident that your study meets or exceeds best
practices in safeguarding the rights of human research participants. I hereby grant you permission to
proceed with your study with the following conditions: (1) If you become aware of any unintended ethical
problems with your study, you will contact the IRB immediately; (2) If someone files a formal complaint to
you regarding your study, you will inform the IRB immediately; (3) Your written and verbal informed
consents include a statement about to whom participants should report any questions or concerns about
your study – first would be to you, then the chair of the IRB’s at Oglethorpe ; (4) If you intend to alter your
methodology in a manner that might reasonably affect a matter of research ethics, you will first submit a
proposal for the change(s) to the IRB; and (5) The permission granted is for one year – following which
you may submit a request for extended approval if you would like to continue the study. Once your study
has concluded, the IRB would like a brief letter for our records that summarizes how the study concluded
and attests to whether or not there were any complaints raised by participants during the study in order for
us to comply with federal regulations.
I wish you well with your data collection and thank you for your well organized approval request
form and accompanying materials. If you have any questions or concerns, do not hesitate to contact me,
Dr. Brad Stone.
Sincerely,
Dr. Brad Stone
Chair, Oglethorpe University Institutional Review Board for Research with Human Participants
Phone: 404-364-8344; Email: bstone@oglethorpe.edu
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Appendix A continued - GSU IRB Approval
Completed Submissions
Study Status:

Approved
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Appendix B – Documentation of Waiver of Consent
Georgia State University
School of Public Health
Informed Consent
Title: A comparison of smokeless tobacco usage in two NCAA baseball programs
Principal Investigator:

Dr. Kimberle Sterling, Andy Farrey

I.
Purpose:
You are invited to participate in a research study. The purpose of the study is to
investigate and compare the patterns of and attitudes toward smokeless tobacco (dip)
usage on an NCAA Division I baseball team and an NCAA Division III baseball team.
You are invited to participate because you are a member of the varsity baseball team. A
total of approximately 40-50 participants will be recruited for this study between the two
teams. Participation will require 15 minutes of your time.
II.

Procedures:

If you decide to participate, you will be asked to fill out a survey on Qualtrics’s
website. Qualtrics specializes in academic research surveys. The survey may be
taken anywhere you choose, but should be taken in a private place and you should
close the browser window upon completing the survey. Please complete it by
October 25, 2013. It is a one-time survey and you have no other obligations upon
completing it. You will not be asked to have any interaction with anyone as a part of
the study.
III.

Risks:

In this study, you will not have any more risks than you would in a normal day of
life. All possible steps will be taken to ensure the confidentiality of the data, and
the data will be stored on a third party firewall-protected and encrypted server.
IV.

Benefits:

Participation in this study may not benefit you personally. Overall, we hope to gain
information about patterns of smokeless tobacco use on collegiate baseball teams.
V.

Voluntary Participation and Withdrawal:

Participation in research is voluntary. You do not have to be in this study. If you
decide to be in the study and change your mind, you have the right to drop out at any
time. You may skip questions or stop participating at any time. Whatever you decide,
there are no consequences.
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VI.

Confidentiality:

We will keep your records private to the extent allowed by law. Only the study’s
Principal Investigator Dr. Kimberle Sterling and Student Investigator Andy Farrey will
have access to the information you provide. Information may also be shared with those
who make sure the study is done correctly (GSU Institutional Review Board, the Office
for Human Research Protection (OHRP). We will not ask for your name so it will not be
on study records. The information you provide will be stored on Qualtric’s firewallprotected and encrypted servers under a strict privacy and security policy. They are
maintained by a third party that specializes in protecting sensitive data and are regularly
checked for intrusions. Please be aware that information sent over the internet might not
be secure, but the only potentially personally identifying information will be your IP
address and we will not collect that information. Georgia State University will not have
access to the survey data. Any information that might point to you will not appear when
we present this study or publish its results. The findings will be summarized and reported
in group form. You will not be identified personally.
VII. Contact Persons:
Contact Dr. Kimberle Sterling at 404-413-1129 or ksterling@gsu.edu or Andy Farrey at 678591-0079 or afarrey1@student.gsu.edu if you have questions, concerns, or complaints about
this study. You can also call if you think you have been harmed by the study. Call Susan
Vogtner in the Georgia State University Office of Research Integrity at 404-413-3513 or
svogtner1@gsu.edu if you want to talk to someone who is not part of the study team. You
can talk about questions, concerns, offer input, obtain information, or suggestions about the
study. You can also call Susan Vogtner if you have questions or concerns about your rights
in this study.
VIII.

Copy of Consent Form to Subject:

You may print a copy of the consent form for your records.
If you are willing to volunteer for this research, please take the survey at your convenience
by February 1, 2014.
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Appendix C – Invitation Emails
OUSubject Line: Smokeless tobacco survey for Oglethorpe University baseball players
Dear Oglethorpe University baseball player,
You are invited to participate in an online survey as part of a research study. You are
receiving this email because you are listed on the varsity roster of the Oglethorpe
University baseball team. Your email address was obtained from the campus directory.
The title of this study is, “A comparison of smokeless tobacco usage in two NCAA
baseball programs and the National College Health Assessment smokeless tobacco data.”
The Principal Investigator is Dr. Kimberle Sterling and the Principal Student Investigator is
Andy Farrey.
This study will look at the usage of smokeless tobacco on Oglethorpe University’s varsity
baseball team and Georgia State University’s varsity baseball team. It will attempt to
examine patterns and frequency of smokeless tobacco use on each team, past history of
smokeless tobacco use, and attitudes toward its use in users and non-users and compare
those values to the National College Health Assessment measurements of smokeless
tobacco use in comparable age groups that are not athlete-specific.
This survey is voluntary and will take less than 15 minutes. The data collected is
confidential and will not be examined by anyone except Dr. Sterling and Andy Farrey, and
names and IP addresses are not being recorded. If you decide to participate, please read the
attached waiver of documentation of consent, then click on the link below and complete the
survey on Qualtric’s website.
If you have questions, do not hesitate to contact Dr. Kimberle Sterling at 404-413-1129 or
ksterling@gsu.edu, or Andy Farrey at 678-591-0079 or afarrey1@student.gsu.edu.
Thank you!
(Link)
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GSUSubject Line: Smokeless tobacco survey for Georgia State University baseball players
Dear Georgia State University baseball player,
You are invited to participate in an online survey as part of a research study. You are
receiving this email because you are listed on the varsity roster of the Georgia State
University baseball team. Your email address was obtained from the Campus Directory.
The title of this study is, “A comparison of smokeless tobacco usage in two NCAA
baseball programs and the National College Health Assessment smokeless tobacco data.”
The Principal Investigator is Dr. Kimberle Sterling and the Principal Student Investigator is
Andy Farrey.
This study will look at the usage of smokeless tobacco on Georgia State University’s
varsity baseball team and Oglethorpe University’s varsity baseball team. It will attempt to
examine patterns and frequency of smokeless tobacco use on each team, past history of
smokeless tobacco use, and attitudes toward its use in users and non-users and compare
those values to the National College Health Assessment measurements of smokeless
tobacco use in comparable age groups that are not athlete-specific.
This survey is voluntary and will take less than 15 minutes. The data collected is
confidential and will not be examined by anyone except Dr. Sterling and Andy Farrey, and
names and IP addresses are not being recorded. If you decide to participate, please read the
attached waiver of documentation of consent, then click on the link below and complete the
survey on Qualtric’s website.
If you have questions, do not hesitate to contact Dr. Kimberle Sterling at 404-413-1129 or
ksterling@gsu.edu, or Andy Farrey at 678-591-0079 or afarrey1@student.gsu.edu.
Thank you!
(Link)
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Appendix D – Survey Instrument
GSU –
Smokeless Tobacco (ST) Use in Collegiate Baseball
Please answer the following questions. I am a Master’s of Public Health
candidate at Georgia State University and I am collecting data for my thesis about use of
ST in collegiate baseball. I am looking for patterns of use and will compare this data to
an identical survey given at Oglethorpe University to their baseball program. If you have
any questions feel free to email me at afarrey11@yahoo.com. Information obtained from
this survey is completely confidential, and participation is voluntary. Please complete
the survey in a private environment and close the browser window when finished. Please
answer honestly.

HISTORY OF SMOKELESS TOBACCO (ST) USE
1.
Have you ever used ST?
a.
Yes
b.
No
2.

How long have you been using ST?
a.
I have never used ST
b.
6 months or less
c.
7 months to a year
d.
A year or two
e.
More than two years
Other: ____________
3.

Have you used ST at least once in the past 30 days?
a.
I have never used ST
b.
Yes
c.
No

4.
Would you classify yourself as a “dipper?” A “dipper” is defined as
someone who uses ST often or regularly.
a.
I have never used ST
b.
Yes
c.
No
d.
Maybe/Not Sure
5.
Do you consider yourself to be a habitual (daily use or use on most days)
ST user?
a.
I have never used ST
b.
Yes
c.
No
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6.

Within the last 30 days, on how many days did you use ST??
a.
I have never used ST
b.
Have used, but not in the last 30 days
c.
1-2 days
d.
3-5 days
e.
6-9 days
f.
10-19 days
g.
20-29 days
h.
All 30 days

7.

If you use ST regularly, how long does it take you to finish one can?
a.
I have never used ST
b.
I do not use enough to buy my own cans
c.
<1 day
d.
1-2 days
e.
3-5 days
f.
6-9 days
g.
10-19 days
h.
20-29 days
i.
All 30 days

BRANDS AND TYPES OF ST USE
1.
What type of ST do you use/prefer?
a.
I have never used ST
b.
Long cut
c.
Fine cut
d.
Snuff
e.
Whole leaves- “chew”
f.
Pouches
g.
Snus
2.

What brand of ST do you typically use?
a.
Skoal/Copenhagen
b.
Grizzly/Kodiak
c.
Timberwolf
d.
Red Man/Beech-nut
e.
Redwood/Kayak
f.
Marlboro/Camel/Triumph/Skoal Snus
g.
Other:_________

BASEBALL AND ST USE
1.
At what types of baseball events do you typically use ST?
a.
I do not use ST
b.
At practices and games
c.
At practices only
d.
At games only
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2.
Is there a team policy about ST? This could be from coaches, training
staff, etc.
a.
Yes
b.
No
c.
Not Sure
d.
Yes but not enforced
3.
Have you ever heard of or seen any disciplinary actions taken against any
player because of ST use?
a.
Yes
b.
No
c.
Not sure
4.

Does ST use bother you or offend you in any way?
a.
Yes
b.
No
c.
I’m indifferent to ST use

5.

Has a teammate (on any team) ever offered ST to you?
a.
Yes
b.
No
c.
Not Sure

6.

Has a coach (on any team) ever offered ST to you?
a.
Yes
b.
No
c.
Not Sure

7.
Is ST use part of your college baseball team’s culture? Specifically, is
there ST use on the field, at parties, meetings, etc.? Please circle all that apply.
a.
On field (games and practices)
b.
Just practices
c.
Just games
d.
At team meetings
e.
At parties/just hanging out
f.
No
g.
Other: ____________
8.

Do the coaches of your current baseball team care about player ST use?
a.
Yes
b.
No
c.
Not sure/Hadn’t noticed
d.
They know about it but don’t mention it
e.
They use it too
f.
Other: ___________________________
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9.

Does the NCAA ban on ST affect your ST use?
a.
I do not use ST
b.
Yes
c.
No
d.
Hadn’t thought about it

ST PRACTICES AND BELIEFS ABOUT ST USE
1.
Are you secretive about your ST use?
a.
I do not use ST
b.
Yes
c.
No
d.
Never thought about it
2.

Are you concerned about the long-term risk often associated with ST?
a.
Yes
b.
No
c.
Hadn’t thought of it

3.
Are you concerned about the long-term risk associated with tobacco use
generally?
a.
Yes
b.
No
c.
Hadn’t thought of it
4.
Do you consider your oral hygiene more important because you use ST?
As in do you make sure to brush your teeth more frequently than you might
otherwise since you use ST?
a.
I do not use ST
b.
Yes
c.
No
d.
Not Sure/Hadn’t thought about it
DEMOGRAPHIC INFORMATION
1.
How old are you?
a.
18
b.
19
c.
20
d.
21
e.
22 or older
2.

What ethnic group do you consider yourself a part of?
a.
White
b.
Black
c.
Hispanic/Latino
d.
Asian
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e.
3.

Other: _________________

What is your current year of college eligibility?
a.
Freshman
b.
Sophomore
c.
Junior
d.
Senior
e.
Other: __________________

4.
Are you a position player or a pitcher (If both, which do you consider your
primary role)?
a.
Position player
b.
Pitcher
c.
Decline to answer
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OUSmokeless Tobacco (ST) Use in Collegiate Baseball
Please answer the following questions. I am a Master’s of Public Health
candidate at Georgia State University and I am collecting data for my thesis about use of
ST in collegiate baseball. I am looking for patterns of use and will compare this data to
an identical survey given at Georgia State University to their baseball program. If you
have any questions feel free to email me at afarrey11@yahoo.com. Information obtained
from this survey is completely confidential, and participation is voluntary. Please
complete the survey in a private environment and close the browser window when
finished. Please answer honestly.

HISTORY OF SMOKELESS TOBACCO (ST) USE
1.
Have you ever used ST?
a.
Yes
b.
No
2.

How long have you been using ST?
a.
I have never used ST
b.
6 months or less
c.
7 months to a year
d.
A year or two
e.
More than two years
Other: ____________
3.

Have you used ST at least once in the past 30 days?
a.
I have never used ST
b.
Yes
c.
No

4.
Would you classify yourself as a “dipper?” A “dipper” is defined as
someone who uses ST often or regularly.
a.
I have never used ST
b.
Yes
c.
No
d.
Maybe/Not Sure
5.
Do you consider yourself to be a habitual (daily use or use on most days)
ST user?
a.
I have never used ST
b.
Yes
c.
No
6.

Within the last 30 days, on how many days did you use ST??
a.
I have never used ST
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b.
c.
d.
e.
f.
g.
h.
7.

Have used, but not in the last 30 days
1-2 days
3-5 days
6-9 days
10-19 days
20-29 days
All 30 days

If you use ST regularly, how long does it take you to finish one can?
a.
I have never used ST
b.
I do not use enough to buy my own cans
c.
<1 day
d.
1-2 days
e.
3-5 days
f.
6-9 days
g.
10-19 days
h.
20-29 days
i.
All 30 days

BRANDS AND TYPES OF ST USE
1.
What type of ST do you use/prefer?
a.
I have never used ST
b.
Long cut
c.
Fine cut
d.
Snuff
e.
Whole leaves- “chew”
f.
Pouches
g.
Snus
2.

What brand of ST do you typically use?
a.
Skoal/Copenhagen
b.
Grizzly/Kodiak
c.
Timberwolf
d.
Red Man/Beech-nut
e.
Redwood/Kayak
f.
Marlboro/Camel/Triumph/Skoal Snus
g.
Other:_________

BASEBALL AND ST USE
1.
At what types of baseball events do you typically use ST?
a.
I do not use ST
b.
At practices and games
c.
At practices only
d.
At games only
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2.
Is there a team policy about ST? This could be from coaches, training
staff, etc.
a.
Yes
b.
No
c.
Not Sure
d.
Yes but not enforced
3.
Have you ever heard of or seen any disciplinary actions taken against any
player because of ST use?
a.
Yes
b.
No
c.
Not sure
4.

Does ST use bother you or offend you in any way?
a.
Yes
b.
No
c.
I’m indifferent to ST use

5.

Has a teammate (on any team) ever offered ST to you?
a.
Yes
b.
No
c.
Not Sure

6.

Has a coach (on any team) ever offered ST to you?
a.
Yes
b.
No
c.
Not Sure

7.
Is ST use part of your college baseball team’s culture? Specifically, is
there ST use on the field, at parties, meetings, etc.? Please circle all that apply.
a.
On field (games and practices)
b.
Just practices
c.
Just games
d.
At team meetings
e.
At parties/just hanging out
f.
No
g.
Other: ____________
8.

Do the coaches of your current baseball team care about player ST use?
a.
Yes
b.
No
c.
Not sure/Hadn’t noticed
d.
They know about it but don’t mention it
e.
They use it too
f.
Other: ___________________________
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9.

Does the NCAA ban on ST affect your ST use?
a.
I do not use ST
b.
Yes
c.
No
d.
Hadn’t thought about it

ST PRACTICES AND BELIEFS ABOUT ST USE
1.
Are you secretive about your ST use?
a.
I do not use ST
b.
Yes
c.
No
d.
Never thought about it
2.

Are you concerned about the long-term risk often associated with ST?
a.
Yes
b.
No
c.
Hadn’t thought of it

3.
Are you concerned about the long-term risk associated with tobacco use
generally?
a.
Yes
b.
No
c.
Hadn’t thought of it
4.
Do you consider your oral hygiene more important because you use ST?
As in do you make sure to brush your teeth more frequently than you might
otherwise since you use ST?
a.
I do not use ST
b.
Yes
c.
No
d.
Not Sure/Hadn’t thought about it
DEMOGRAPHIC INFORMATION
1.
How old are you?
a.
18
b.
19
c.
20
d.
21
e.
22 or older
2.

What ethnic group do you consider yourself a part of?
a.
White
b.
Black
c.
Hispanic/Latino
d.
Asian
e.
Other: _________________
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3.

What is your current year of college eligibility?
a.
Freshman
b.
Sophomore
c.
Junior
d.
Senior
e.
Other: __________________

4.
Are you a position player or a pitcher (If both, which do you consider your
primary role)?
a.
Position player
b.
Pitcher
c.
Decline to answer
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Appendix E – Full Survey Results
Table of Demographics, History of ST Use, and Brands/Types of ST Use
DEMOGRAPHICS
School

Total

GSU

N=22/% of

OU

Total

N=8; % of GSU N=14; % of OU
18

Count / %

2

25%

3

21.4%

5

22.7%

19

Count / %

0

0%

3

21.4%

3

3.6%

20

Count / %

3

37.5%

3

21.4%

6

77.3%

21

Count / %

0

0%

3

21.4%

3

13.6%

22 or older

Count / %

3

37.5%

2

14.3%

5

22.7%

White

Count / %

8

100%

14

100%

22

100.0%

Freshman

Count / %

2

25%

3

21.4%

5

22.7%

Sophomore

Count / %

1

12.5%

4

28.6%

5

22.7%

Current Year of

Junior

Count / %

2

25%

2

14.3%

4

18.2%

Athletic Eligibility

Senior

Count / %

1

12.5%

3

21.4%

4

18.2%

Count / %

2

25%

2

14.3%

4

18.2%

Age

Race/Ethnic Group

Other (Red-shirted
for example)
Position Player or

Position player

Count / %

5

62.5%

10

71.4%

15

68.2%

Pitcher

Pitcher

Count / %

3

37.5%

4

28.6%

7

31.8%

HISTORY OF ST USE
Have you ever used

Yes

Count / %

6

75%

5

35.7%

11

50%

ST?

No

Count / %

2

25%

9

64.3%

11

50%

I have never used ST Count / %

2

25%

9

64.3%

11

50%

7 months to a year

Count / %

0

0%

1

7.1%

1

4.5%

A year or two

Count / %

2

25%

1

7.1%

3

13.6%

More than two years

Count / %

4

50%

2

14.3%

6

27.3%

Other

Count / %

0

0%

1

7.1%

1

4.5%

Have you used ST

Yes

Count / %

5

62.5%

2

14.3%

7

31.8%

once in the past 30

No

Count / %

1

12.5%

5

35.7%

6

27.3%

days?

I have never used ST Count / %

2

25%

7

50%

9

40.9%

Do you consider

Yes

Count / %

5

62.5%

2

14.3%

7

31.8%

yourself to be a

No

Count / %

1

12.5%

5

35.7%

6

27.3%

I have never used ST

Count / %

2

25%

7

50%

9

40.9%

I do not use ST

Count / %

3

37.5%

9

64.4%

12

54.3%

How long have you
been using ST?

habitual (daily use or
use on most days)
ST user?
Within the last 30
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days, on how many

Have used, but not in

days did you use

the last 30 days

ST?

Count / %

0

0%

3

21.4%

3

13.6%

20-29

Count / %

2

25%

0

0%

2

9.1%

All 30 days

Count / %

3

37.5%

2

14.3%

5

22.7%

I have never used ST

Count / %

2

25%

9

64.3%

11

50%

Count / %

1

12.5%

2

14.3%

3

13.6%

1-2 days

Count / %

3

37.5%

1

7.1%

4

18.2%

3-5 days

Count / %

0

0%

1

7.1%

1

4.5%

6-9 days

Count / %

1

12.5%

0

0%

1

4.5%

10-19 days

Count / %

1

12.5%

1

7.1%

2

9.1%

I do not use enough
If you use ST
regularly, how long
does it take you to
finish one can?

to buy my own cans

BRANDS AND TYPE OF ST USE
What type of ST do
you use/prefer?

What brand of ST do
you typically use?

I do not use ST

Count / %

3

37.5%

10

71.4%

13

59.1%

Long cut

Count / %

3

37.5%

4

28.6%

7

31.8%

Pouches

Count / %

2

25%

0

0%

2

9.2%

I do not use ST

Count / %

3

37.5%

10

71.4%

13

59.1%

Copenhagen

Count / %

2

25%

2

14.3%

4

18.2%

Grizzly/Kodiak

Count / %

3

37.5%

2

14.3%

5

22.7%

Table of Baseball and ST Use
BASEBALL AND ST USE
School

At what types of

I do not use ST

baseball events do

At practices and

you typically use

games

ST?

Total

GSU

OU

N=22/% of

N=8; % of GSU

N=14; % of OU

Total

Count / %

3

37.5%

10

71.4%

13

59.1%

Count / %

4

50%

3

21.4%

7

31.8%

At practices only

Count / %

1

12.5%

1

7.1%

2

9.1%

Yes

Count / %

2

25%

4

28.6%

6

27.3%

policy about ST?

No

Count / %

0

0%

2

14.3%

2

9.1%

This could be from

Not sure

Count / %

1

12.5%

2

14.3%

3

13.6%

Count / %

5

62.5%

6

42.9%

11

50%

Is there a team

coaches, training
staff, etc.

Yes, but not
enforced

Have you ever

Yes

Count / %

0

0%

5

37.5%

5

22.7%

heard of or seen

No

Count / %

8

100%

8

57.1%

16

72.7%
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any disciplinary
actions taken

Count

0

0%

1

7.1%

1

4.5%

Does ST use bother Yes

Count / %

0

0%

4

28.6%

4

18.2%

or offend you in any

Not Sure

Count / %

1

12.5%

2

14.3%

3

13.6%

way?

No

Count / %

7

87.5%

8

57.1%

15

68.2%

Has a teammate (on Yes

Count / %

8

100%

12

87.5%

20

90.9%

any team) ever

Maybe

Count / %

0

0%

1

7.1%

1

4.5%

offered ST to you?

No

Count / %

0

0%

1

7.1%

1

4.5%

Has a coach (on

Yes

Count / %

2

25%

2

14.3%

4

18.2%

any team) ever

No

Count / %

5

62.5%

11

78.6%

16

72.7%

offered ST to you?

Not sure

Count / %

1

12.5%

1

7.1%

2

9.1%

Count / %

6

75%

12

87.5%

18

81.8%

Count / %

1

12.5%

2

14.3%

3

13.6%

Count / %

0

0%

0

0%

0

0%

Count / %

5

62.5%

8

8

13

59.1%

Count / %

7

87.5%

11

57.1%

18

81.8%

No
Other

Count / %

1

12.5%

1

7.1%

2

9.1%

Count / %

1

12.5%

1

7.1%

2

9.1%

No

Count / %

2

25%

8

57.1%

10

45.5%

Count / %

2

25%

3

21.4%

5

22.7%

Count / %

2

25%

3

21.4%

5

22.7%

They use it too

Count / %

2

25%

0

0%

2

9.1%

I do not use ST

Count / %

3

37.5%

10

71.4%

13

59.1%

Yes

Count / %

1

12.5%

0

0%

1

4.5%

Count / %

4

50%

3

21.4%

7

31.8%

Count / %

0

0%

1

7.1%

1

4.5%

against any player

Not sure

because of ST use?

On field (games/
practices)
Just Practices
Is ST use part of

Just Games

your college

At team meetings/

baseball team’s

functions

culture?

At parties/ just
hanging out

Do your current

Not sure/Hadn't

coaches care about

noticed

player ST use

They know about it

personally?

but don't mention it

Does the NCAA ban

on ST affect your ST No
use?

Hadn't thought about
it
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Table of ST Practices and Beliefs about ST Use
ST PRACTICES AND BELIEFS ABOUT ST USE
School

Total

GSU

N=22/% of

OU

N=8; % of GSU N=14; % of OU

Are you secretive
about your ST use?

Total

I do not use ST

Count / %

3

37.5%

10

71.4%

13

59.1%

Yes

Count / %

1

12.5%

0

0%

1

4.5%

Count /%

1

12.5%

0

0%

1

4.5%

Count / %

3

37.5%

4

28.6%

7

31.8%

Only during
games/practices
No

Are you concerned

I do not use ST

Count / %

3

37.5%

10

71.4%

13

59.1%

about the possible

Yes

Count / %

3

37.5%

2

14.3%

5

22.7%

long-term health

No

Count / %

0

0%

1

7.1%

1

4.5%

2

25%

1

7.1%

3

13.6%

risks associated with Hadn't thought

Count / %

ST?

about it

Are you concerned

I do not use ST

Count / %

3

37.5%

10

71.4%

13

59.1%

Yes

Count / %

4

50%

4

28.6%

8

36.4%

1

12.5%

0

0%

1

4.5%

about the long-term
health risks
associated with

Hadn't thought

tobacco generally?

about it

Do you consider

I do not use ST

Count / %

3

37.5%

10

71.4$

13

59.1%

your oral hygiene

Yes

Count / %

4

50%

2

14.3%

6

27.3%

more important

No

Count / %

0

0%

1

7.1%

1

4.5%

because you use

Hadn't thought

ST?

about it

1

12.5%

1

7.1%

2

9.1%

Count / %

Count / %
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